Skip to content
Clinical Trials – home

Infertility male Diagnostics

5 / 8 trials open to patients7 countries

In short

Male infertility diagnostics involves a series of tests and examinations that help doctors understand why a man may have difficulty fathering a child. These evaluations combine physical examinations, laboratory analyses, and sometimes imaging studies to identify issues with sperm production, hormone levels, or structural problems in the reproductive system.

Key points

  • Male factors contribute to about half of all infertility cases, making male evaluation essential for any couple struggling to conceive.
  • Semen analysis is the cornerstone diagnostic test and usually requires at least two separate samples for accurate results.
  • Even healthy couples have only a 20-25% chance of conceiving each month, so fertility challenges are more common than many realize.
  • Male infertility diagnostics can uncover serious health conditions beyond fertility issues, including testicular cancer and hormonal disorders.
  • Physical examination can identify correctable problems like varicoceles, which are enlarged veins that can damage sperm production.
  • Lifestyle factors including smoking, alcohol use, diet, stress, and exposure to heat can all impact sperm health and should be discussed during evaluation.
  • Both partners should be evaluated together, as infertility is a couples' issue with potential contributing factors from each side.
  • Diagnostic testing for clinical trial participation may be more comprehensive than standard workups and follows specific enrollment criteria.

Introduction: Who Should Seek Diagnostic Testing

If you and your partner have been trying to conceive for at least one year without success, it may be time to consider diagnostic testing for male infertility. This timeframe is shorter if your female partner is over 35 years old—in that case, doctors recommend seeking evaluation after six months of unsuccessful attempts.

The evaluation becomes more urgent if certain risk factors are present. Men should seek testing sooner if they have a history of testicular trauma, previous surgery in the genital area such as hernia repairs, undescended testicles during childhood, or if they have undergone cancer treatments including chemotherapy or radiation. Other situations that warrant earlier evaluation include difficulty with sexual function, such as problems achieving or maintaining an erection, difficulty with ejaculation, or reduced sexual desire.

Both partners should be investigated together, as infertility is a couples' issue. In about 20% of cases, the male partner is solely responsible for infertility, while in another 30-40% of cases, male factors contribute along with female factors. Overall, male factors play a role in about half of all infertility cases.

It's important to remember that infertility is defined by health organizations as the inability of a couple to achieve pregnancy after one year of regular, unprotected sexual intercourse. This definition means that conception is naturally a complex process—even young, healthy couples only have about a 20-25% chance of conceiving each month.

Classic Diagnostic Methods

Medical History and Physical Examination

The diagnostic journey typically begins with a comprehensive discussion about your health and personal history. Your doctor will ask detailed questions about your sexual habits, including how often you have intercourse and whether you experience any difficulties during sexual activity. Questions will also cover your sexual development during puberty, any past illnesses or injuries, surgeries you've had (especially in the genital or abdominal area), and whether you've been exposed to toxic chemicals, high temperatures, or radiation.

The doctor will inquire about lifestyle factors that can affect fertility. These include whether you smoke tobacco or marijuana, your alcohol consumption habits, use of any medications or illegal drugs (particularly anabolic steroids), your diet and exercise patterns, stress levels at work and home, and whether you've had any sexually transmitted infections. Your family's medical history may also be discussed, as some genetic conditions can affect fertility.

A physical examination follows the medical history. The doctor will examine your genitals, looking at the size and consistency of your testicles, checking for any lumps, swelling, or pain in the testicular area. The examination may identify enlarged veins around the testicle, a condition called varicocele, which means varicose veins in the scrotum. Varicoceles can trap blood around the testicle, increasing its temperature and potentially damaging sperm production. The doctor will also check for signs of hormonal imbalances, such as abnormal breast growth (called gynecomastia) or decreased facial and body hair.

Semen Analysis

The semen analysis is the cornerstone of male infertility diagnosis. This laboratory test examines the fluid that is ejaculated to assess the health and viability of sperm. To collect a sample, you typically provide it by masturbating and ejaculating into a special sterile container at the doctor's office or clinic. Some men, for religious or cultural reasons, may prefer to collect the sample using a special condom during intercourse with their partner.

The laboratory examines multiple characteristics of the semen sample. First, they measure the volume—normally, there should be at least 1.5 milliliters of fluid, roughly equivalent to half a teaspoon. They count the number of sperm present, looking for at least 15 million sperm per milliliter or a total of at least 39 million sperm in the entire ejaculate. The analysis also evaluates sperm motility, which means the ability of sperm to move and swim properly—at least 40% of sperm should be capable of movement for optimal fertility.

The shape of sperm, called morphology, is also examined under a microscope. Healthy sperm typically have oval heads and long tails that work together to propel them forward. At least 4% of sperm should have normal shape and structure. The laboratory may also check the pH level of the semen, which measures its acidity or alkalinity, and look for signs of infections or other abnormalities.

Because sperm counts can fluctuate significantly from one sample to another, a single abnormal result doesn't necessarily indicate a problem. Doctors typically order at least two separate semen analyses performed over a period of time to ensure accurate results. If the first test shows abnormalities, additional testing will be recommended.

Hormonal Testing

Blood tests to measure hormone levels may be recommended if the semen analysis shows abnormal results or if the physical examination suggests a hormonal imbalance. These tests evaluate hormones produced by the brain and testicles that regulate sperm production and sexual function.

The hormones typically measured include testosterone, which is the primary male sex hormone produced by the testicles. Low testosterone levels can indicate problems with the testicles themselves or with the brain regions that control them—specifically the hypothalamus and pituitary gland. Sometimes male infertility is associated with low testosterone production, which can cause symptoms like tiredness, erectile dysfunction, depression, weight gain, and lack of energy.

Other hormones that may be tested include follicle-stimulating hormone and luteinizing hormone, both produced by the pituitary gland in the brain. These hormones signal the testicles to produce sperm and testosterone. Abnormal levels can help doctors understand whether the problem lies in the testicles themselves or in the signaling from the brain.

Genetic Testing

In some cases, genetic testing may be recommended to identify inherited conditions that affect fertility. Some genetic disorders, such as Klinefelter syndrome (where a man has an extra X chromosome) or myotonic dystrophy, can cause infertility. Tiny missing fragments of the male Y chromosome may also be responsible for problems with sperm production in some men.

Scrotal Ultrasound

An ultrasound of the scrotum uses sound waves to create images of the testicles and surrounding structures. This imaging test can help identify physical problems such as varicoceles, blockages in the tubes that carry sperm, or abnormalities in the testicles themselves. The procedure is painless and non-invasive—a technician simply applies a gel to the scrotal area and moves a handheld device over the skin to capture images.

Additional Specialized Tests

If initial testing reveals certain problems, your doctor may recommend more specialized evaluations. These might include tests to check for infections, such as sexually transmitted diseases, which can cause scarring and blockages in the reproductive tract. Untreated infections are a major cause of male infertility.

For men with no sperm in their semen—a condition called azoospermia—additional procedures may be needed to determine whether the problem is a blockage preventing sperm from exiting or a failure of the testicles to produce sperm. In some cases, doctors may perform a testicular biopsy, taking a small tissue sample from the testicle to examine whether sperm are being produced.

Diagnostics for Clinical Trial Qualification

When considering participation in clinical trials for male infertility treatments, specific diagnostic criteria are typically required. Clinical trials use standardized tests to ensure that participants meet the study's enrollment requirements and to establish baseline measurements for comparing treatment outcomes.

Semen analysis remains the primary qualification tool for most male infertility clinical trials. Researchers use the same parameters described earlier—sperm count, motility, morphology, and semen volume—but may have specific thresholds that define eligibility. For example, a trial testing a treatment for low sperm count might only enroll men whose sperm concentration falls below a certain number per milliliter.

Hormone level measurements through blood tests are also standard requirements for clinical trial qualification. Researchers need to document baseline testosterone levels and other hormones before any intervention begins. This allows them to track changes that occur during the trial and determine whether the experimental treatment affects hormone production.

Physical examination findings, particularly the presence or absence of varicocele, may influence eligibility for certain trials. Some studies specifically recruit men with varicoceles to test surgical or non-surgical treatments, while others may exclude men with this condition to focus on different causes of infertility.

Genetic testing may be required for trials investigating treatments for genetically-caused infertility. Understanding a participant's genetic makeup helps researchers determine whether specific genetic conditions respond differently to experimental interventions.

Clinical trials may also require documentation of the couple's pregnancy attempts over time, confirmation that the female partner has been evaluated for fertility issues, and verification that both partners meet age requirements. Some trials exclude men with certain medical conditions or those taking specific medications that could interfere with study results.

Before enrolling in a clinical trial, participants typically undergo comprehensive baseline testing that may be more extensive than standard diagnostic workups. This thorough evaluation ensures that researchers have complete information about each participant's fertility status and overall health before treatment begins.

Did you know?

  1. Even in young, healthy couples, the monthly chance of achieving pregnancy is only about 20-25%, highlighting that conception is naturally a complex process with many variables.
  2. Approximately 80% of a man's testicles are dedicated specifically to sperm production, emphasizing the organ's primary reproductive function.
  3. Problems with sperm numbers or quality may be linked to tiny missing fragments of the male Y chromosome, showing how subtle genetic changes can significantly impact fertility.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Infertility male

Recruiting trials first

See all 8 trials →
Quick filters

8 clinical trials in this condition

Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Sponsor:Region Hovedstaden
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Pentoxifylline
  • Sponsor:Prokrea Bcn S.L.

Infertility male

Not yet recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Martin-Luther-Universitaet Halle-Wittenberg
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Isotretinoin
  • Sponsor:Les Hopitaux Universitaires De Strasbourg
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Follitropin Alfa
  • Sponsor:Instituto Bernabeu S.L.

Infertility male

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Denosumab
  • Sponsor:Region Hovedstaden
See all 8 trials →filters applied: condition = Infertility male

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).